.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Expert Insights on Treatment Selection in Advanced Systemic Mastocytosis

EP. 1: Dr Kuykendall on Molecular Testing in Systemic Mastocytosis

April 5th 2023

Andrew Kuykendall, MD, discusses the importance of testing for mutations in KIT and other genes in patients with systemic mastocytosis.

EP. 2: Dr Kuykendall on AEs With Midostaurin and Avapritinib in Advanced Systemic Mastocytosis

April 5th 2023

Andrew Kuykendall, MD, discusses the occurrence and management of adverse effects associated with midostaurin and avapritinib in patients with advanced systemic mastocytosis.

EP. 3: Dr Kuykendall on Emerging Therapies in Systemic Mastocytosis

April 6th 2023

Andrew Kuykendall, MD, discusses agents currently in development for patients with systemic mastocytosis and how these investigational therapies may fit into the overall treatment paradigm for this disease.

EP. 4: Expert Insights on Treatment Selection in Advanced Systemic Mastocytosis

June 7th 2023